ThromboGenics Receives Positive CHMP Opinion for JETREA®

News   Apr 24, 2013

 
ThromboGenics Receives Positive CHMP Opinion for JETREA®
 
 
 

RELATED ARTICLES

Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the Body

News

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

READ MORE

Symmetry-breaking Method Opens Way for Bioactive Compounds

News

EPFL chemists have developed a new catalytic method for symmetry breaking. Published in Angewandte Chemie, the method can help synthesize important building blocks for bioactive compounds such as anticancer drugs.

READ MORE

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News

An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial researchers have reported.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE